Garcia-Romeu, A., Davis, A. K., Erowid, F., Erowid, E., Griffiths, R. R., & Johnson, M. W. | Journal of Psychopharmacology | 14 May 2019
Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care.
Dyck, E. | Journal of psychoactive drugs | 1 March 2019
Preller, K. H., Razi, A., Zeidman, P., Stämpfli, P., Friston, K. J., & Vollenweider, F. X. | Proceedings of the National Academy of Sciences | 12 February 2019
Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats
Sakloth, F., Leggett, E., Moerke, M. J., Townsend, E. A., Banks, M. L., & Negus, S. S. | Experimental and clinical psychopharmacology | 10 January 2019
Anderson, T., Petranker, R., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L. A., Hui, K., & Farb, N. A. | Psychopharmacology | 2 January 2019
Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. | Pharmacology & therapeutics | 4 December 2018
The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial.
Yanakieva, S., Polychroni, N., Family, N., Williams, L. T., Luke, D. P., & Terhune, D. B. | Psychopharmacology | 26 November 2018
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions
Garcia-Romeu, A., & Richards, W. A. | International Review of Psychiatry | 13 November 2018
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Russ, S., Nutt, D., ... & Carhart-Harris, R. L. | Frontiers in pharmacology | 2 November 2018
Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition.
Atasoy, S., Vohryzek, J., Deco, G., Carhart-Harris, R. L., & Kringelbach, M. L. | Progress in brain research | 25 October 2018
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
Preller, K. H., Burt, J. B., Ji, J. L., Schleifer, C. H., Adkinson, B. D., Stämpfli, P., & Vollenweider, F. X. | eLife | 25 October 2018
Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review.
Bodnár, K. J., & Kakuk, P. | Medicine, Health Care and Philosophy | 16 October 2018
de Coo, I. F., Naber, W. C., Wilbrink, L. A., Haan, J., Ferrari, M. D., & Fronczek, R. | Cephalalgia | 5 October 2018
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug
Jalal, B. | Psychopharmacology | 5 October 2018
Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.
Müller, F., Liechti, M. E., Lang, U. E., Borgwardt, S., Wilson, M. R., Webb, A., ... & Lutz, K. | Progress in brain research | 28 September 2018
Bayne, T., & Carter, O. | Neuroscience of consciousness | 19 September 2018
Carhart‐Harris, R. L. | World Psychiatry | 7 September 2018
Millière, R., Carhart-Harris, R. L., Roseman, L., Trautwein, F. M., & Berkovich-Ohana, A. | Frontiers in psychology | 4 September 2018
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
De, D. G., Enns, J. P., Nuñez, N. A., Posa, L., & Gobbi, G. | Progress in brain research | 31 August 2018
Alper, K., Dong, B., Shah, R., Sershen, H., & Vinod, K. Y. | Frontiers in pharmacology | 31 August 2018
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
dos Santos, R. G., Bouso, J. C., Alcázar-Córcoles, M. Á., & Hallak, J. E. | Expert review of clinical pharmacology | 13 August 2018
Ross, S. | International Review of Psychiatry | 13 August 2018
Schenberg, E. E. S. | Frontiers in pharmacology | 5 July 2018
Jungaberle, H., Thal, S., Zeuch, A., Rougemont-Bücking, A., von Heyden, M., Aicher, H., & Scheidegger, M. | Neuropharmacology | 29 June 2018